日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

登録内容を編集ファイル形式で保存
EndNote (UTF-8)
 
ダウンロード電子メール
  Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP

Bokelmann, L., Nickel, O., Maricic, T., Pääbo, S., Meyer, M., Borte, S., & Riesenberg, S. (2021). Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP. Nature Communications, 12(1):. doi:10.1038/s41467-021-21627-0.

Item is

基本情報

非表示:
アイテムのパーマリンク: https://hdl.handle.net/21.11116/0000-0008-18EC-4 版のパーマリンク: https://hdl.handle.net/21.11116/0000-000F-4997-5
資料種別: 学術論文

ファイル

非表示: ファイル
:
Bokelmann_Point-of-care_NatComm_2021.pdf (出版社版), 2MB
ファイルのパーマリンク:
https://hdl.handle.net/21.11116/0000-0008-18FA-4
ファイル名:
Bokelmann_Point-of-care_NatComm_2021.pdf
説明:
-
OA-Status:
Gold
閲覧制限:
公開
MIMEタイプ / チェックサム:
application/pdf / [MD5]
技術的なメタデータ:
著作権日付:
2021
著作権情報:
This article is licensed under a Creative CommonsAttribution 4.0 International License, which permits use, sharing,adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the CreativeCommons license, and indicate if changes were made. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unlessindicated otherwise in a credit line to the material. If material is not included in thearticle’s Creative Commons license and your intended use is not permitted by statutoryregulation or exceeds the permitted use, you will need to obtain permission directly fromthe copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
:
Bokelmann_Point-of-care_NatComm_2021_Suppl..pdf (付録資料), 4MB
ファイルのパーマリンク:
https://hdl.handle.net/21.11116/0000-0008-1900-C
ファイル名:
Bokelmann_Point-of-care_NatComm_2021_Suppl.pdf
説明:
-
OA-Status:
Not specified
閲覧制限:
公開
MIMEタイプ / チェックサム:
application/pdf / [MD5]
技術的なメタデータ:
著作権日付:
2021
著作権情報:
This article is licensed under a Creative CommonsAttribution 4.0 International License, which permits use, sharing,adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the CreativeCommons license, and indicate if changes were made. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unlessindicated otherwise in a credit line to the material. If material is not included in thearticle’s Creative Commons license and your intended use is not permitted by statutoryregulation or exceeds the permitted use, you will need to obtain permission directly fromthe copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

関連URL

非表示:
説明:
Preprint
OA-Status:
Not specified

作成者

非表示:
 作成者:
Bokelmann, Lukas1, 2, 著者                 
Nickel, Olaf, 著者
Maricic, Tomislav2, 著者                 
Pääbo, Svante2, 著者                 
Meyer, Matthias3, 著者           
Borte, Stephan, 著者
Riesenberg, Stephan2, 著者                 
所属:
1The Leipzig School of Human Origins (IMPRS), Max Planck Institute for Evolutionary Anthropology, Max Planck Society, ou_1497688              
2Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society, ou_1497672              
3Advanced DNA Sequencing Techniques, Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society, ou_2074332              

内容説明

非表示:
キーワード: -
 要旨: Efforts to contain the spread of SARS-CoV-2 have spurred the need for reliable, rapid, and cost-effective diagnostic methods which can be applied to large numbers of people. However, current standard protocols for the detection of viral nucleic acids while sensitive, require a high level of automation and sophisticated laboratory equipment to achieve throughputs that allow whole communities to be tested on a regular basis. Here we present Cap-iLAMP (capture and improved loop-mediated isothermal amplification) which combines a hybridization capture-based RNA extraction of gargle lavage samples with an improved colorimetric RT-LAMP assay and smartphone-based color scoring. Cap-iLAMP is compatible with point-of-care testing and enables the detection of SARS-CoV-2 positive samples in less than one hour. In contrast to direct addition of the sample to improved LAMP (iLAMP), Cap-iLAMP prevents false positives and allows single positive samples to be detected in pools of 25 negative samples, reducing the reagent cost per test to ~1 Euro per individual.

資料詳細

非表示:
言語: eng - English
 日付: 2021-03-05
 出版の状態: オンラインで出版済み
 ページ: -
 出版情報: -
 目次: -
 査読: 査読あり
 識別子(DOI, ISBNなど): DOI: 10.1038/s41467-021-21627-0
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

非表示:
出版物名: Nature Communications
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: 12 (1) 通巻号: 1467 開始・終了ページ: - 識別子(ISBN, ISSN, DOIなど): ISSN: 2041-1723